Bulletin from the Annual General Meeting in Hansa Biopharma

/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, has today on June 30,...

Related Keywords

Sweden , United States , Stockholm , American , Hansa Biopharma , Andreas Eggert , Klaus Sindahl , Eva Nilsag , Anders Gersel Pedersen , Hilary Malone , Prnewswire Hansa Biopharma , Peter Nicklin , Katja Margell , Share Rights Program , Audit Committee , Remuneration Committee , Hansa Biopharma Option Program , Nomination Committee , Exchange Commission , Head Of Corporate Communications , Us Committee , Scientific Committee , Nasdaq Stockholm , Annual General , Annual General Meeting , Chief Executive Officer , Mats Blom , American Depositary Shares , Rights Program , Adoption Program , Annual General Meetings , Corporate Communications , Hansa Biopharma Ab ,